Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary

Background: As biosimilars have become available in various parts of the world, the International Psoriasis Council has reviewed aspects of their use. Objective: To provide consensus statements from the Biosimilar Working Group about the use of biosimilars in patients with psoriasis. Methods: A semi...

Полное описание

Библиографические подробности
Главные авторы:	Arnon D. Cohen, MD, MPH, PhD, Ronald Vender, MD, FRCPC, Luigi Naldi, MD, Robert E. Kalb, MD, Tiago Torres, MD, PhD, Murlidhar Rajagopalan, MD, Joelle van der Walt, PhD, Lluís Puig, MD (Hon), PhD, Helen S. Young, MB ChB, PhD, FRCP
Формат:	Статья
Язык:	English
Опубликовано:	Elsevier 2020-12-01
Серии:	JAAD International
Предметы:	biosimilars interchangeability International Psoriasis Council psoriasis switching tumor necrosis factor inhibitors
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2666328720300523

Схожие документы

An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
по: Zhou X, и др.
Опубликовано: (2021-07-01)

Biosimilars
по: Emel Bülbül Başkan
Опубликовано: (2022-04-01)

Biosimilar Agents for Psoriasis Treatment: The Perspective of Portuguese Patients
по: Alexandra Azevedo, и др.
Опубликовано: (2018-09-01)

Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis
по: Changkun Li, и др.
Опубликовано: (2023-12-01)

Portuguese Position Paper on the Use of Biosimilars in Psoriasis
по: Tiago Torres, и др.
Опубликовано: (2016-09-01)

Psoriasis vulgaris with fibrokeratoma from pityriasis amiantacea
по: Chihiro Shiiya, MD, и др.
Опубликовано: (2017-05-01)

Psoriasis and adverse pregnancy outcomes: A nationwide case-control study in 491,274 women in DenmarkCapsule Summary
по: Cæcilie Bachdal Johansen, MD, и др.
Опубликовано: (2022-06-01)

Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study
по: Megna M, и др.
Опубликовано: (2022-07-01)

Psoriasis coxsackium
по: Daniel W. Cole, MD, и др.
Опубликовано: (2022-07-01)

Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis
по: Rachel C. Ruda, и др.
Опубликовано: (2023-12-01)

A review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs
по: Rebecca Reese, и др.
Опубликовано: (2024-12-01)

Mild-to-moderate severity of psoriasis may be assessed remotely based on photographs and self-reported extent of skin involvementCapsule Summary
по: Zarqa Ali, MD, PhD, и др.
Опубликовано: (2023-06-01)

Real-world outcomes in patients with malignancy and moderate-to-severe psoriasis treated with guselkumabCapsule Summary
по: Tamara Gracia Cazaña, MD, PhD, и др.
Опубликовано: (2024-09-01)

Clinical efficacy of risankizumab in patients with psoriasis: A Japanese case series
по: Kanako Tsunoda, MD, PhD, и др.
Опубликовано: (2024-09-01)

Ustekinumab Biosimilars
по: Elena Carmona-Rocha, и др.
Опубликовано: (2024-11-01)

Authorisation of Non-Innovator Biotherapeutic (Biosimilar) Products in the USA
по: A. A. Soldatov, и др.
Опубликовано: (2019-03-01)

Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
по: Alan Menter
Опубликовано: (2023-10-01)

Late-onset development of psoriasis in Japan: a population-based cohort studyCapsule Summary
по: Haruka Goto, MD, и др.
Опубликовано: (2021-03-01)

On the Regulatory Approval Pathway of Biosimilar Products
по: Jun Wang, и др.
Опубликовано: (2012-03-01)

Sociodemographic factors have very little influence on adherence to topical drugs in patients with psoriasis
по: Mathias Tiedemann Svendsen, MD, PhD, и др.
Опубликовано: (2024-12-01)

Prognostic implications of high-sensitivity cardiac troponin in patients with suspected myocardial infarction with or without psoriasis
по: Sanaz A. Guldmann, MD, DPhil, и др.
Опубликовано: (2023-06-01)

Among psoriasis patients in Flanders, Belgium, a third has sexual dysfunction and almost half depression symptoms
по: Roel Van Overmeire, PhD, и др.
Опубликовано: (2025-02-01)

Facial psoriasis in a mask-like distribution
по: Cameron M.B. Zachary, MS, и др.
Опубликовано: (2021-01-01)

Injection site reactions due to the use of biologics in patients with psoriasis: A retrospective study
по: Yun Kyung Jang, MD, и др.
Опубликовано: (2023-03-01)

Comparative efficacy and safety of adalimumab biosimilar (BCD-057) and innovator in patients with psoriasis vulgaris. Results of the BCD-057-2/CALYPSO phase III international, multicenter, randomized double-blind clinical trial
по: Т. V. Korotaeva, и др.
Опубликовано: (2018-12-01)

Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
по: Mohammed Alqahtani, и др.
Опубликовано: (2024-11-01)

Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast]
по: Cohen SB, и др.
Опубликовано: (2023-10-01)

Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study
по: Yuliya Lytvyn, PhD, и др.
Опубликовано: (2022-03-01)

SAFETY AND CLINICAL EFFICACY IN BIOSIMILAR SUBSTITUTION
по: João Pedro Fernandes, и др.
Опубликовано: (2015-03-01)

SAFETY AND CLINICAL EFFICACY IN BIOSIMILAR SUBSTITUTION
по: João Pedro Fernandes, и др.
Опубликовано: (2015-01-01)

Successful treatment of palmoplantar psoriasis with chemical peeling and gentian violet
по: Jeffrey A. Bubley, MD, и др.
Опубликовано: (2021-11-01)

Biosimilar SB17 versus reference ustekinumab in moderate to severe plaque psoriasis after switching: phase 3 study results up to week 52
по: Steven R. Feldman, и др.
Опубликовано: (2024-12-01)

Biosimilars, the journey has begun
по: Alba Martos-Rosa, и др.
Опубликовано: (2015-01-01)

A pustular psoriasis flare treated with calcium supplementation
по: Laure Masson, MD, и др.
Опубликовано: (2021-06-01)

Nanotomography of lesional skin using electron microscopy reveals cytosolic release of nuclear DNA in psoriasis
по: Eric Lindberg, PhD, и др.
Опубликовано: (2021-03-01)

The Problem of Anti-Cytokine Therapy in Psoriasis Patients
по: Ramina K. Keshileva, PhD
Опубликовано: (2012-09-01)

Cardiovascular Complications During Delivery Hospitalization in Patients With Psoriasis
по: Ankit Agrawal, MD, и др.
Опубликовано: (2025-02-01)

Onset of rupioid psoriasis after vasodilatory regimen initiation in a patient with pulmonary arterial hypertension
по: Uros Rakita, MSc, и др.
Опубликовано: (2021-06-01)

Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review
по: Ronald Vender, MD, и др.
Опубликовано: (2022-09-01)

Societal impact for patients with psoriasis: A nationwide Swedish register studyCapsule Summary
по: Henrike Häbel, PhD, и др.
Опубликовано: (2021-06-01)